<SEC-DOCUMENT>0001470831-25-000129.txt : 20250814
<SEC-HEADER>0001470831-25-000129.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814145707
ACCESSION NUMBER:		0001470831-25-000129
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814
EFFECTIVENESS DATE:		20250814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KAZIA THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-554781
		FILM NUMBER:		251217807

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		THREE INTERNATIONAL TOWERS LEVEL 24,
		STREET 2:		300 BARANGAROO AVENUE
		CITY:			SYDNEY NSW
		PROVINCE COUNTRY:   	C3
		ZIP:			2000
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		THREE INTERNATIONAL TOWERS LEVEL 24,
		STREET 2:		300 BARANGAROO AVENUE
		CITY:			SYDNEY NSW
		PROVINCE COUNTRY:   	C3
		ZIP:			2000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVOGEN LTD
		DATE OF NAME CHANGE:	19981228
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0708</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001075880</cik>
        <entityName>KAZIA THERAPEUTICS LTD</entityName>
        <issuerAddress>
            <street1>THREE INTERNATIONAL TOWERS LEVEL 24,</street1>
            <street2>300 BARANGAROO AVENUE</street2>
            <city>SYDNEY NSW</city>
            <stateOrCountry>C3</stateOrCountry>
            <stateOrCountryDescription>AUSTRALIA</stateOrCountryDescription>
            <zipCode>2000</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>01161298780088</issuerPhoneNumber>
        <jurisdictionOfInc>AUSTRALIA</jurisdictionOfInc>
        <edgarPreviousNameList>
            <previousName>NOVOGEN LTD</previousName>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>John</firstName>
                <lastName>Friend</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Level 24, Three International Towers</street1>
                <street2>300 Barangaroo Avenue</street2>
                <city>Sydney</city>
                <stateOrCountry>C3</stateOrCountry>
                <stateOrCountryDescription>AUSTRALIA</stateOrCountryDescription>
                <zipCode>2000</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Bryce</firstName>
                <lastName>Carmine</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Level 24, Three International Towers</street1>
                <street2>300 Barangaroo Avenue</street2>
                <city>Sydney</city>
                <stateOrCountry>C3</stateOrCountry>
                <stateOrCountryDescription>AUSTRALIA</stateOrCountryDescription>
                <zipCode>2000</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Steven</firstName>
                <lastName>Coffey</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Level 24, Three International Towers</street1>
                <street2>300 Barangaroo Avenue</street2>
                <city>Sydney</city>
                <stateOrCountry>C3</stateOrCountry>
                <stateOrCountryDescription>AUSTRALIA</stateOrCountryDescription>
                <zipCode>2000</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Ebru</firstName>
                <lastName>Davidson</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Level 24, Three International Towers</street1>
                <street2>300 Barangaroo Avenue</street2>
                <city>Sydney</city>
                <stateOrCountry>C3</stateOrCountry>
                <stateOrCountryDescription>AUSTRALIA</stateOrCountryDescription>
                <zipCode>2000</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Robert</firstName>
                <lastName>Apple</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Level 24, Three International Towers</street1>
                <street2>300 Barangaroo Avenue</street2>
                <city>Sydney</city>
                <stateOrCountry>C3</stateOrCountry>
                <stateOrCountryDescription>AUSTRALIA</stateOrCountryDescription>
                <zipCode>2000</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Jeffrey</firstName>
                <lastName>Bonacorda</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Level 24, Three International Towers</street1>
                <street2>300 Barangaroo Avenue</street2>
                <city>Sydney</city>
                <stateOrCountry>C3</stateOrCountry>
                <stateOrCountryDescription>AUSTRALIA</stateOrCountryDescription>
                <zipCode>2000</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Elissa</firstName>
                <lastName>Hansen</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Level 24, Three International Towers</street1>
                <street2>300 Barangaroo Avenue</street2>
                <city>Sydney</city>
                <stateOrCountry>C3</stateOrCountry>
                <stateOrCountryDescription>AUSTRALIA</stateOrCountryDescription>
                <zipCode>2000</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Biotechnology</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06b</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2025-08-04</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
            <isOptionToAcquireType>true</isOptionToAcquireType>
            <isSecurityToBeAcquiredType>true</isSecurityToBeAcquiredType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>2050013</totalOfferingAmount>
            <totalAmountSold>2050013</totalAmountSold>
            <totalRemaining>0</totalRemaining>
            <clarificationOfResponse>Includes pre-funded warrants to purchase up to 204,547 ADSs, each representing 500 ordinary shares, and aggregate exercise price of ADSs underlying pre-funded warrants, each exercisable for one ADS at exercise price $0.0001 per ADS.</clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>4</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>KAZIA THERAPEUTICS LTD</issuerName>
                <signatureName>/s/ John Friend</signatureName>
                <nameOfSigner>John Friend</nameOfSigner>
                <signatureTitle>Chief Executive Officer</signatureTitle>
                <signatureDate>2025-08-14</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
